A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide.

MLA

Tsouri, Steliana, et al. “A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide.” Pharmaceuticals (14248247), vol. 17, no. 3, Mar. 2024, p. 365. EBSCOhost, https://doi.org/10.3390/ph17030365.

APA

Tsouri, S., Tselo, E., Premetis, G. E., Furlan, V., Pantiora, P. D., Mavroidi, B., Matiadis, D., Pelecanou, M., Papageorgiou, A. C., Bren, U., Sagnou, M., & Labrou, N. E. (2024). A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide. Pharmaceuticals (14248247), 17(3), 365. https://doi.org/10.3390/ph17030365

Chicago

Tsouri, Steliana, Evanthia Tselo, Georgios E. Premetis, Veronika Furlan, Panagiota D. Pantiora, Barbara Mavroidi, Dimitris Matiadis, et al. 2024. “A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide.” Pharmaceuticals (14248247) 17 (3): 365. doi:10.3390/ph17030365.